NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1

American Journal of Pathology

Volumn 169, Issue 2, 2006, Pages 553-565

  Tanji, Kunikazu ^a   Tanaka, Tomoaki ^a,b   Mori, Fumiaki ^c   Kito, Katsumi ^d   Takahashi, Hitoshi ^e   Wakabayashi, Koichi ^c   Kamitani, Tetsu ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEDD8 PROTEIN; PROTEASOME; PROTEIN; PROTEIN NUB1; SYNPHILIN 1; UNCLASSIFIED DRUG;

ARTICLE; BRAIN; CELL CULTURE; CELL INCLUSION; CELL STRAIN HEK293; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 33746644725     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.051067     Document Type: Article

References (43)

1. Kamitani T, Kito K, Nguyen HP, Yeh ETH: Characterization of NEDD8, a developmentally down-regulated ubiquitin-like molecule. J Biol Chem 1997, 272:28557-28562
2. Wada H, Yeh ETH, Kamitani T: Identification of NEDD8-conjugation site in human cullin-2. Biochem Biophys Res Commun 1999, 257:100-105
3. Stickle NH, Chung J, Klco JM, Hill RP, Kaelin Jr WG, Ohh M: pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development. Mol Cell Biol 2004, 24:3251-3261
4. Xirodimas DP, Saville MK, Bourdon JC, Hay RT, Lane DP: Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 2004, 118:83-97
5. Yeh ETH, Gong L, Kamitani T: Ubiquitin-like proteins: new wines in new bottles. Gene 2000, 248:1-14
6. Kito K, Yeh ETH, Kamitani T: NUB1, a NEDD8-interacting protein, is induced by interferon and downregulates the NEDD8 expression. J Biol Chem 2001, 276:20603-20609
7. Kamitani T, Kito K, Fukuda-Kamitani T, Yeh ETH: Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem 2001, 276:46655-46660
8. Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein JJ, Margolis RL, Troncoso JC, Lanahan AA, Worley PF, Dawson VL, Dawson TM, Ross CA: Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet 1999, 22:110-114
9. Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, Takahashi H: Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol (Berl) 1998, 96:445-452
10. Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H: Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann Neurol 2000, 47:521-523
11. Wakabayashi K, Engelender S, Tanaka Y, Yoshimoto M, Mori F, Tsuji S, Ross CA, Takahashi H: Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders. Acta Neuropathol (Berl) 2002, 103:209-214
12. Lang AE, Lozano AM: Parkinson's disease. First of two parts. N Engl J Med 1998, 339:1044-1053
13. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ: Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 2001, 293:263-269
14. Mori F, Nishie M, Piao YS, Kito K, Kamitani T, Takahashi H, Wakabayashi K: Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Neuropathol Appl Neurobiol 2005, 31:53-61
15. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047
16. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O: Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998, 18:106-108
17. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608
18. Marx FP, Holzmann C, Strauss KM, Li L, Eberhardt O, Gerhardt E, Cookson MR, Hernandez D, Farrer MJ, Kachergus J, Engelender S, Ross CA, Berger K, Schols L, Schulz JB, Riess O, Kruger R: Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Hum Mol Genet 2003, 12:1223-1231
19. Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, Iwatsubo T, Murayama S: Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 2003, 62:644-654
20. Tanaka T, Yeh ET, Kamitani P. NUB1-mediated targeting of the ubiquitin precursor UbC1 for its C-terminal hydrolysis. Eur J Biochem 2004, 271:972-982
21. Tanaka T, Kawashima H, Yeh ETH, Kamitani T: Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L. J Biol Chem 2003, 278:32905-32913
22. Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei C-F, Chang H-M, Yeh ETH: Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, Sentrin. J Immunol 1996, 157:4277-4281
23. Kamitani T, Nguyen HP, Yeh ETH: Activation-induced aggregation and processing of the human Fas antigen-detection with cytoplasmic domain specific antibodies. J Biol Chem 1997, 272:22307-22314
24. Kamitani T, Suzuki H, Yano S: An antibody reacting with splenic red pulp macrophages in the sera of patients with rheumatic diseases. Clin Immunol Immunopathol 1991, 58:217-235
25. Ito T, Niwa J, Hishikawa N, Ishigaki S, Doyu M, Sobue G: Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1. J Biol Chem 2003, 278:29106-29114
26. van der Spuy J, Cheetham ME: The Leber congenital amaurosis protein AIPL1 modulates the nuclear translocation of NUB1 and suppresses inclusion formation by NUB1 fragments. J Biol Chem 2004, 279:48038-48047
27. Wada H, Yeh ETH, Kamitani T: A dominant negative Ubc12 mutant sequesters NEDD8 and inhibits NEDD8-conjugation in vivo. J Biol Chem 2000, 275:17008-17015
28. Ribeiro CS, Carneiro K, Ross CA, Menezes JR, Engelender S: Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synuclein. J Biol Chem 2002, 277:23927-23933
29. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T: Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998, 152:879-884
30. Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara H, Kawai M: Immunoelectron-microscopic demonstration of NACP/alpha-synuclein- epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 1998, 808:93-100
31. Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM: Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med 2001, 7:1144-1150
32. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M: Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840
33. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M: Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998, 95:6469-6473
34. Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H: NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 1997, 239:45-48
35. Takahashi H, Wakabayashi K: The cellular pathology of Parkinson's disease. Neuropathology 2001, 21:315-322
36. Kuazi AD, Kito K, Abe Y, Shin R-W, Kamitani T, Ueda N: NEDD8 protein is involved in ubiquitinated inclusion bodies. J Pathol 2003, 199:259-266
37. Iwatsubo T, Yamaguchi H, Fujimuro M, Yokosawa H, Ihara Y, Trojanowski JQ, Lee VM: Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am J Pathol 1996, 148:1517-1529
38. O'Farrell C, Murphy DD, Petrucelli L, Singleton AB, Hussey J, Farrer M, Hardy J, Dickson DW, Cookson MR: Transfected synphilin-1 forms cytoplasmic inclusions in HEK293 cells. Brain Res Mol Brain Res 2001, 97:94-102
39. Nagano Y, Yamashita H, Takahashi T, Kishida S, Nakamura T, Iseki E, Hattori N, Mizuno Y, Kikuchi A, Matsumoto M: Siah-1 facilitates ubiquitination and degradation of synphilin-1. J Biol Chem 2003, 278:51504-51514
40. Liani E, Eyal A, Avraham E, Shemer R, Szargel R, Berg D, Bornemann A, Riess O, Ross CA, Rott R, Engelender S: Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. Proc Natl Acad Sci USA 2004, 101:5500-5505
41. Doss-Pepe EW, Chen L, Madura K: Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine63-linked multiubiquitin chains. J Biol Chem 2005, 280:16619-16624
42. Lim KL, Dawson VL, Dawson TM: Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases? Neurobiol Aging 2006, 27:524-529
43. Kanaya K, Sohocki MM, Kamitani T: Abolished interaction of NUB1 with mutant AIPL1 involved in Leber congenital amaurosis. Biochem Biophys Res Commun 2004, 317:768-773